News
Adding atezolizumab to chemo doesn’t worsen QOL in early TNBC
After an initial decline, quality of life measures rebounded for patients treated with atezolizumab or placebo plus chemotherapy.
News
Durable responses with anti-BCMA CAR T-cell for multiple myeloma
Seventy-two percent of patients with relapsed/refractory multiple myeloma had ongoing responses at the time of data cutoff in the CARTITUDE-1...
News
AASLD 2020: A clinical news roundup
A panel of reviewers highlighted abstracts from the digital edition of the 2020 Liver Meeting in the annual Clinical News Debrief.
News
Pronounced racial differences in HBsAg loss after stopping nucleos(t)ide
Patients of White background had a nearly sixfold higher chance for functional cure of hepatitis B infection.
News
HCC rates slow in cities, continue to climb in rural areas
Disparities in hepatocellular carcinoma incidence rates between urban and rural areas vary by race/ethnicity.
News
Liver-related deaths decline after Medicaid expansion under ACA
Investment in Medicaid expansions paid off in fewer liver-related deaths and a decrease in racial/ethnic disparities.
News
Liquid biopsy captures key NASH pathology hallmarks
Scanning for key proteins in serum identified fibrosis, inflammation, hepatocyte ballooning, and steatosis with high accuracy.
News
Sjögren’s symptom clusters may identify treatment options
Patients with Sjögren’s syndrome can be grouped into one of four symptom clusters that can inform research and potentially targeted therapies.
News
JIA guideline calls for earlier use of targeted therapies
Patients with juvenile idiopathic arthritis can benefit from earlier introduction of biologic DMARDs, an expert consensus panel said.
News
RECIPE trial cooks up gout therapy improvement
Serum uric acid levels were significantly lower at 12 and 24 weeks for patients with refractory gout who received pegloticase plus mycophenolate...